Publication | Closed Access

Cytotoxicity of AMANTADIG – a semisynthetic digitoxigenin derivative – alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+-ATPase inhibition

Molecular PharmacologyMedicinal ChemistryUrologyNa+/k+-atpase InhibitionMedicineCellular PharmacologyClinical PharmacologyPharmacotherapyAnti-cancer AgentAmantadig –PharmacologyDrug Discovery